• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病:对啮齿动物模型的重新思考。

Parkinson's disease: a rethink of rodent models.

作者信息

Melrose Heather L, Lincoln Sarah J, Tyndall Glenn M, Farrer Matthew J

机构信息

Department of Neuroscience, Genetics of Parkinsonism and Related Disorders, Morris K. Udall Parkinson' Disease Research Center of Excellence, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL, 32224, USA.

出版信息

Exp Brain Res. 2006 Aug;173(2):196-204. doi: 10.1007/s00221-006-0461-3. Epub 2006 Apr 26.

DOI:10.1007/s00221-006-0461-3
PMID:16639500
Abstract

Parkinson's disease (PD) is a multifactorial disease with a complex etiology that results from genetic risk factors, environmental exposures and most likely a combination of both. Rodent models of parkinsonism aim to reproduce key pathogenic features of the syndrome including movement disorder induced by the progressive loss of dopaminergic neurons in the substantia nigra, accompanied by the formation of alpha-synuclein containing Lewy body inclusions. Despite the creation of many excellent models, both chemically induced and genetically engineered, there is none that accurately demonstrates these features. Recent pathological staging studies in man have also emphasized the significant non-CNS component of PD that has yet to be tackled. Herein, we summarize rodent models of PD and what they offer to the field, and suggest future challenges and opportunities.

摘要

帕金森病(PD)是一种多因素疾病,病因复杂,由遗传风险因素、环境暴露以及两者的综合作用导致。帕金森病的啮齿动物模型旨在重现该综合征的关键致病特征,包括黑质中多巴胺能神经元逐渐丧失所引发的运动障碍,同时伴有含α-突触核蛋白的路易小体包涵体的形成。尽管已经创建了许多优秀的模型,包括化学诱导模型和基因工程模型,但没有一个能准确展示这些特征。最近对人类的病理分期研究也强调了帕金森病尚未得到解决的重要非中枢神经系统成分。在此,我们总结帕金森病的啮齿动物模型及其为该领域带来的贡献,并提出未来的挑战和机遇。

相似文献

1
Parkinson's disease: a rethink of rodent models.帕金森病:对啮齿动物模型的重新思考。
Exp Brain Res. 2006 Aug;173(2):196-204. doi: 10.1007/s00221-006-0461-3. Epub 2006 Apr 26.
2
Decreased expression of serum- and glucocorticoid-inducible kinase 1 (SGK1) promotes alpha-synuclein increase related with down-regulation of dopaminergic cell in the Substantia Nigra of chronic MPTP-induced Parkinsonism mice and in SH-SY5Y cells.血清和糖皮质激素诱导激酶 1(SGK1)表达降低促进慢性 MPTP 诱导的帕金森病小鼠黑质多巴胺能神经元中与α-突触核蛋白增加相关的下调和 SH-SY5Y 细胞。
Gene. 2018 Jun 30;661:189-195. doi: 10.1016/j.gene.2018.03.086. Epub 2018 Mar 29.
3
Back and to the Future: From Neurotoxin-Induced to Human Parkinson's Disease Models.《回到未来:从神经毒素诱导的帕金森病模型到人类帕金森病模型》
Curr Protoc Neurosci. 2020 Mar;91(1):e88. doi: 10.1002/cpns.88.
4
How to judge animal models of Parkinson's disease in terms of neuroprotection.如何从神经保护角度判断帕金森病动物模型。
J Neural Transm Suppl. 2006(70):255-60. doi: 10.1007/978-3-211-45295-0_39.
5
TLR4 deficiency has a protective effect in the MPTP/probenecid mouse model of Parkinson's disease.TLR4 缺陷在 MPTP/丙磺舒小鼠帕金森病模型中具有保护作用。
Acta Pharmacol Sin. 2019 Dec;40(12):1503-1512. doi: 10.1038/s41401-019-0280-2. Epub 2019 Aug 6.
6
The rotenone model of parkinsonism--the five years inspection.帕金森病的鱼藤酮模型——五年观察
J Neural Transm Suppl. 2006(70):269-72. doi: 10.1007/978-3-211-45295-0_41.
7
Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.重印本:重新探讨氧化应激和线粒体功能障碍在帕金森病发病机制中的作用——类似于安非他命类药物滥用的影响。
Free Radic Biol Med. 2013 Sep;62:186-201. doi: 10.1016/j.freeradbiomed.2013.05.042. Epub 2013 Jun 3.
8
Targeted Overexpression of α-Synuclein by rAAV2/1 Vectors Induces Progressive Nigrostriatal Degeneration and Increases Vulnerability to MPTP in Mouse.rAAV2/1载体靶向过表达α-突触核蛋白可诱导小鼠进行性黑质纹状体变性并增加对MPTP的易感性。
PLoS One. 2015 Jun 26;10(6):e0131281. doi: 10.1371/journal.pone.0131281. eCollection 2015.
9
Parkinson's disease: genetic versus toxin-induced rodent models.帕金森病:基因诱导与毒素诱导的啮齿动物模型
FEBS J. 2008 Apr;275(7):1384-1391. doi: 10.1111/j.1742-4658.2008.06302.x. Epub 2008 Feb 12.
10
Development and characterisation of a novel rat model of Parkinson's disease induced by sequential intranigral administration of AAV-α-synuclein and the pesticide, rotenone.序贯立体定位脑内注射 AAV-α-突触核蛋白和农药鱼藤酮诱导新型帕金森病大鼠模型的建立与特征。
Neuroscience. 2012 Feb 17;203:170-9. doi: 10.1016/j.neuroscience.2011.12.011. Epub 2011 Dec 13.

引用本文的文献

1
Innovative treatment targeting gangliosides aimed at blocking the formation of neurotoxic α-synuclein oligomers in Parkinson's disease.针对神经节苷脂的创新疗法旨在阻止帕金森病中神经毒性α-突触核蛋白寡聚体的形成。
Glycoconj J. 2022 Feb;39(1):1-11. doi: 10.1007/s10719-021-10012-0. Epub 2021 Jul 30.
2
Progress toward Alzheimer's disease treatment: Leveraging the Achilles' heel of Aβ oligomers?阿尔茨海默病治疗的进展:利用 Aβ 寡聚物的致命弱点?
Protein Sci. 2020 Aug;29(8):1748-1759. doi: 10.1002/pro.3906. Epub 2020 Jul 13.
3
[Cellular replacement strategies and adult neurogenesis in idiopathic Parkinson's disease].

本文引用的文献

1
Efficient recombination-based methods for bacterial artificial chromosome fusion and mutagenesis.基于重组的高效细菌人工染色体融合与诱变方法。
Gene. 2006 Apr 12;371(1):136-43. doi: 10.1016/j.gene.2005.11.034. Epub 2006 Feb 17.
2
LRRK2 is expressed in areas affected by Parkinson's disease in the adult mouse brain.LRRK2在成年小鼠大脑中受帕金森病影响的区域表达。
Eur J Neurosci. 2006 Feb;23(3):659-66. doi: 10.1111/j.1460-9568.2006.04616.x.
3
Lrrk2 and Lewy body disease.富含亮氨酸重复激酶2与路易体病
[特发性帕金森病中的细胞替代策略与成人神经发生]
Nervenarzt. 2016 Aug;87(8):805-13. doi: 10.1007/s00115-016-0157-2.
4
Novel (Hetero)arylalkenyl propargylamine compounds are protective in toxin-induced models of Parkinson's disease.新型(杂)芳基烯基炔丙胺化合物在帕金森病毒素诱导模型中具有保护作用。
Mol Neurodegener. 2016 Jan 13;11:6. doi: 10.1186/s13024-015-0067-y.
5
Mitochondrial and Ubiquitin Proteasome System Dysfunction in Ageing and Disease: Two Sides of the Same Coin?衰老与疾病中的线粒体和泛素蛋白酶体系统功能障碍:同一枚硬币的两面?
Int J Mol Sci. 2015 Aug 17;16(8):19458-76. doi: 10.3390/ijms160819458.
6
Myristoylation confers noncanonical AMPK functions in autophagy selectivity and mitochondrial surveillance.豆蔻酰化赋予自噬选择性和线粒体监视中非经典 AMPK 功能。
Nat Commun. 2015 Aug 14;6:7926. doi: 10.1038/ncomms8926.
7
Exposure to mitochondrial genotoxins and dopaminergic neurodegeneration in Caenorhabditis elegans.秀丽隐杆线虫中线粒体基因毒素暴露与多巴胺能神经变性
PLoS One. 2014 Dec 8;9(12):e114459. doi: 10.1371/journal.pone.0114459. eCollection 2014.
8
Adult hippocampal neurogenesis in Parkinson's disease: impact on neuronal survival and plasticity.帕金森病中的成人海马神经发生:对神经元存活和可塑性的影响。
Neural Plast. 2014;2014:454696. doi: 10.1155/2014/454696. Epub 2014 Jul 3.
9
Advances in non-dopaminergic treatments for Parkinson's disease.帕金森病非多巴胺能治疗的进展
Front Neurosci. 2014 May 22;8:113. doi: 10.3389/fnins.2014.00113. eCollection 2014.
10
Mitochondrial oxidative stress in aging and healthspan.衰老与健康寿命中的线粒体氧化应激
Longev Healthspan. 2014 May 1;3:6. doi: 10.1186/2046-2395-3-6. eCollection 2014.
Ann Neurol. 2006 Feb;59(2):388-93. doi: 10.1002/ana.20731.
4
Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death.帕金森病α-突触核蛋白转基因小鼠出现神经元线粒体变性和细胞死亡。
J Neurosci. 2006 Jan 4;26(1):41-50. doi: 10.1523/JNEUROSCI.4308-05.2006.
5
Toxin-induced models of Parkinson's disease.毒素诱导的帕金森病模型。
NeuroRx. 2005 Jul;2(3):484-94. doi: 10.1602/neurorx.2.3.484.
6
Parkin-deficient mice are not more sensitive to 6-hydroxydopamine or methamphetamine neurotoxicity.帕金森蛋白缺陷型小鼠对6-羟基多巴胺或甲基苯丙胺神经毒性并不更敏感。
BMC Neurosci. 2005 Dec 24;6:71. doi: 10.1186/1471-2202-6-71.
7
The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity.导致帕金森病的LRRK2突变I2020T与激酶活性增加有关。
Hum Mol Genet. 2006 Jan 15;15(2):223-32. doi: 10.1093/hmg/ddi439. Epub 2005 Dec 1.
8
Mice lacking alpha-synuclein are resistant to mitochondrial toxins.缺乏α-突触核蛋白的小鼠对线粒体毒素具有抗性。
Neurobiol Dis. 2006 Mar;21(3):541-8. doi: 10.1016/j.nbd.2005.08.018. Epub 2005 Nov 18.
9
Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity.富含亮氨酸重复激酶2中与帕金森病相关的突变增强激酶活性。
Proc Natl Acad Sci U S A. 2005 Nov 15;102(46):16842-7. doi: 10.1073/pnas.0507360102. Epub 2005 Nov 3.
10
Lrrk2 pathogenic substitutions in Parkinson's disease.帕金森病中Lrrk2的致病性替代
Neurogenetics. 2005 Dec;6(4):171-7. doi: 10.1007/s10048-005-0005-1. Epub 2005 Sep 17.